Delpor, Inc. Announces the Issuance of 2 New US Patents Based on its...

Delpor has exclusive rights to the patented technology and has several product candidates in development, including 3-6 month formulations of exenatide, liraglutide, and basal insulin.(PRWeb April 23, 2015)Read the full story at http://www.prweb.com/releases/2015/04/prweb12671977.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news